Savalia and colleagues have shown that administration of nanoformulated SOD, Poly-l-lysine (PLL50)-polyethylene glycerol (PEG) copper/zinc superoxide dismutase (CuZnSOD) could scavenge excessive superoxide anions and decrease blood pressure in a mouse model of Ang II-induced hypertension. This evidence concerns the gene SOD1 and hypertensive disorder.